The UK IPF Registry has provided new insights into the evolving landscape of idiopathic pulmonary fibrosis management.

Williams, who has performed the National Anthem at baseball stadiums as part of Boehringer Ingelheim’s Breathless campaign, ...

Conduit Pharmaceuticals Inc. (NASDAQ:CDT – Get Free Report) was the target of a significant increase in short interest during the month of February. As of February 15th, there was short interest ...

Argenx had cash, cash equivalents, and other short-term investments totaling $3.4 billion as of the end of 2024, making it well-positioned to continue funding its pipeline and commercialization ...

Epilepsy, a misunderstood neurological disorder, affects millions worldwide, but with proper treatment, individuals can lead ...

Piper Sandler reaffirmed their overweight rating on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) in a report ...

Incyte (Nasdaq: INCY) today announced that multiple abstracts featuring new data from its dermatology portfolio will be presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting, ...

About Fabhalta® (iptacopan) Fabhalta (iptacopan) is an oral, Factor B inhibitor of the alternative complement pathway 6-7.

Cheryl and Vera, two sisters bound by love and resilience, have not only faced these challenges head-on but raised awareness on rare disease.